REZIPRES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rezipres, and what generic alternatives are available?
Rezipres is a drug marketed by Dr Reddys Labs Sa and is included in one NDA.
The generic ingredient in REZIPRES is ephedrine hydrochloride. There are sixty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ephedrine hydrochloride profile page.
Summary for REZIPRES
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Patent Applications: | 709 |
Drug Prices: | Drug price information for REZIPRES |
What excipients (inactive ingredients) are in REZIPRES? | REZIPRES excipients list |
DailyMed Link: | REZIPRES at DailyMed |
Pharmacology for REZIPRES
Drug Class | Norepinephrine Releasing Agent alpha-Adrenergic Agonist beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Increased Norepinephrine Activity |
Anatomical Therapeutic Chemical (ATC) Classes for REZIPRES
US Patents and Regulatory Information for REZIPRES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-001 | Jun 14, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-004 | Dec 7, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-002 | Jun 14, 2021 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |